Medtronic, Inc. (MDT) PT Lowered to $125 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Medtronic reports full year and fourth quarter fiscal year 2022 financial results; announces 8% dividend increase
May 26, 2022 6:46 AM EDTMid-single digit FY22 revenue growth; Q4 results affected by temporary global supply chain impacts and China lockdowns
DUBLIN, May 26, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2022, which ended April 29, 2022.
Key Highlights
FY22 revenue increased 5% reported and organicFY22 GAAP diluted EPS increased 40%; non-GAAP diluted EPS increased 26%FY22 cash flow from operations of $7.3 billion increased 18%; FY22 free cash flow of $6.0 billion increased 22%Quarterly dividend... More